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A B S T R A C T
Chronic disseminated intravascular coagulation (DIC) is a well-known complication of aortic aneurysm.
A 91-year-old Japanese woman was admitted to our hospital because of massive purpura of the lower
limbs. The presence of abdominal aortic aneurysm (AAA) had been pointed out from the age of 80 years,
and its diameter had gradually increased. The AAA was composed of two portions, that is, a large upper
and a small lower portion, and a large mural thrombosis was observed in the lower portion. The
laboratory data led to the diagnosis of DIC, and AAA was the only identiﬁable cause of coagulopathy. The
time course of exacerbation of AAA was consistent with the progression of thrombocytopenia and
purpura. Therefore, we concluded that AAA was the underlying cause of DIC. Since DIC in aortic
aneurysms is associated with excessive ﬁbrinolysis, tranexamic acid was administered as anti-
ﬁbrinolytic therapy. After that, coagulopathy was drastically improved. Our patient responded
successfully to anti-ﬁbrinolytic therapy for coagulopathy. The present case illustrates the importance of
evaluation of the diameter of an aneurysm as well as intraluminal thrombosis, which may play an
important role in coagulopathy including DIC. It is necessary to monitor coagulation and ﬁbrinolysis for
the follow-up of patients with AAA.
<Learning objective: We present a case report of an aged Japanese woman with abdominal aortic
aneurysm associated with disseminated intravascular coagulation, and anti-ﬁbrinolytic therapy
drastically ameliorated her condition. Our case illustrates the importance of evaluation of the diameter
of an aneurysm as well as conducting follow-up monitoring of coagulation and ﬁbrinolysis.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Societies are aging at a greater rate worldwide, particularly in
Japan, and are creating a burden on healthcare systems to maintain
adequate levels of care for aged patients with atherosclerotic
cardiovascular diseases, including aortic aneurysm. For example,
the number of patients with abdominal aortic aneurysm (AAA)
is increasing [1,2]. The surgical or intravascular treatment of AAA
is well established; however, the presence of other diseases
associated with AAA complicates the therapeutic strategy.* Corresponding author at: Department of Cardiovascular Medicine, Kobe Rosai
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complication of aortic aneurysm that was ﬁrst reported by Fine
et al. in 1967 associated with a case of dissecting aortic aneurysm
[3]. Among preoperative patients with aortic aneurysms, 40% have
elevated levels of ﬁbrinogen degradation products and 4%
experience clinically overt DIC [4]. The clinical picture of DIC in
aortic aneurysm includes distinctive features of typical DIC
manifested as sepsis, in which ﬁbrinolytic processes are activated
and are associated with greater risk of bleeding. Here, we describe
the case of an aged Japanese woman with AAA associated with DIC,
who was successfully treated with anti-ﬁbrinolytic therapy.
Case report
A 91-year-old woman was admitted to our hospital because of
massive purpura of bilateral lower limbs. The presence of AAA hads reserved.
Fig. 1. Marked purpura on her lower legs at admission.
Table 1 Laboratory data on admission.
Blood cell count Biochemistry Coagulation tests
WBC 5600/mm3 CRP 1.2 mg/dl PT 15.6 s (10–14)
RBC 173  104/mm3 T-bil 0.47 mg/dl PT-INR 1.77
Ht 17.1% D-bil 0.18 mg/dl APTT 57 s (23–42)
Hb 5.1 g/dl BUN 47.0 mg/dl Fibrinogen 82 mg/dl
MCV 99 ﬂ Cr 1.8 mg/dl AT-III 87%
MCH 29.5 pg Na 140 mEq/l FDP 107.2 mg/ml
MCHC 29.8% Cl 113 mEq/l D-Dimer 65.7 mg/ml
Plt 4.4  104/mm3 Fe 33 mg/dl
Reti 50% Ferritin 192.5 ng/ml
AAA, abdominal aortic aneurysm; DIC, disseminated intravascular coagulation;
FDP, ﬁbrin/ﬁbrinogen degradation products; AT-III, antithrombin-III; EVAR,
endovascular aneurysm repair; TAT, thrombin–antithrombin complex; PIC,
plasmin–a2 plasmin inhibitor complex; t-PA, tissue plasminogen activator; CRP,
C-reactive protein; T-bil, total bilirubin; D-bil, direct bilirubin; PT-INR, interna-
tional normalized ratio of prothrombin time.
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gradually increased. Therefore, surgical therapy was recommended
to her several times; however, she refused obstinately for the
operation. Her medical history included a partial gastrectomy for
gastric cancer. Six months before the admission, she noticed mild
subcutaneous bleeding at a bruise on a lower limb that was
spreading widely to both limbs. On admission, the blood pressure
was 114/70 mmHg and pulse rate was 60 beats per minute, and skin
oxygen saturation was 98%. The jugular vein was not dilated, andFig. 2.
(A) Three-dimensional imaging of enhanced computed tomography showing 
aneurysm was composed of two portions, that is, a large upper and a small low
large mural thrombosis. The dimensions of the upper and lower portions atejection systolic murmur at the 2nd right sternal border was audible.
A large pulsating mass (7 cm  11 cm) was palpable on the
abdomen, and marked purpura was observed on her lower legs
(Fig. 1). Laboratory data indicated anemia, thrombocytopenia
(hemoglobin 5.1 g/dl, platelet count, 4.4  104/mL), and abnormal
levels of serum coagulation factors [ﬁbrinogen, 82 mg/dl; ﬁbrin/
ﬁbrinogen degradation products (FDP), 107.2 mg/ml; D-dimer,
65.7 mg/ml; antithrombin-III (AT-III), 87%] (Table 1). According tothe presence of a saccular aneurysm of the abdominal aorta. The abdominal aortic
er portion. (B) The cross-section imaging of abdominal aortic aneurysm showing
 the scanned plain were 92 mm and 47 mm, respectively.
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Fig. 3. Clinical course before hospitalization. AAA, abdominal aortic aneurysm.
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13 points.
Enhanced computed tomography revealed the presence of a
saccular aneurysm of the abdominal aorta, and the AAA was
composed of two portions, that is, a large upper and a small lower
portion. The dimension of the upper and lower portions at the
scanned plain was 92 mm and 47 mm, respectively, and a large
mural thrombosis was observed in the lower portion (Fig. 2).
For the investigation of the etiology of anemia and thrombocy-
topenia, bone marrow aspiration and endoscopic examination
were performed, and their results showed no abnormality. The
laboratory data led to a diagnosis of DIC, and AAA was the only
identiﬁable cause of coagulopathy. The time course of exacerbation
of AAA was consistent with the progression of thrombocytopenia,
anemia, and purpura (Fig. 3). Therefore, we concluded from these
ﬁndings that AAA was the underlying cause of DIC.
To control the condition of DIC, continuous infusion of heparin
(12,000 U/day) and nafamostat mesilate (60 mg/day) was initially
administered for several days, and AT-III and fresh-frozen plasma
were administered for the consumption of coagulation factors. But,
the DIC score was unchanged. Thereafter, the administration of
nafamostat mesilate was given up, because of hyperkalemia.
Instead of nafamostat mesilate, we started to administer camostat
mesilate. However, purpura of the lower limbs and her general
conditions were exacerbated; therefore, we considered that these
drugs did not affect her clinical conditions or coagulopathy (Fig. 4).
DIC in aortic aneurysms is associated with excessive ﬁbrinoly-
sis, which may induce the bleeding tendency. Our case showed
bleeding tendency, and we detected markedly elevated levels of
FDP and D-dimer. These ﬁndings suggested excessive ﬁbrinolysis;
therefore, tranexamic acid was administered as anti-ﬁbrinolytic
therapy. Two days later, coagulopathy was drastically improved,Fig. 4. Clinical course after hospitalization. FDP, ﬁbrinogen degradation products.
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topenia, and purpura became less severe (Fig. 4). Because she was
at extremely high-risk of rupture, we proposed endovascular
aneurysm repair (EVAR) of AAA to her; however, she refused it.
After the improvement in the bleeding tendency, she and her
family eagerly desired to go back home. Since the continuous
administration of heparin forced the patient to be hospitalized, the
intravenous administration of heparin was switched to warfarin
carefully. She was discharged after converting from heparin to
warfarin therapy.
Discussion
DIC is characterized by systemic activation of coagulation
leading to organ failure through the development of ﬁbrin clots
that may cause bleeding because of insufﬁcient levels of platelets
and coagulation factors. Siebert and Natelson proposed the
following criteria for DIC associated with AAA [6] as follows:
chronic bleeding, consumptive coagulopathy, reversal of laborato-
ry data after aneurysm repair, and maintenance of the values for
3 months. We did not repair the AAA of the patient reported here;
however, the correlation between the time course of exacerbation
of AAA with the progression of coagulopathy indicates their
association.
Among the characteristics of DIC associated with aortic
aneurysm, ﬁbrinolysis is markedly enhanced, and bleeding
tendency is prominent. This ﬁbrinolysis-dominant DIC is charac-
terized by the activation of both coagulation and ﬁbrinolysis. The
criteria of enhanced-ﬁbrinolytic-type DIC are as follows. (1)
Prerequisite: thrombin–antithrombin complex (TAT) 20 mg/L
and plasmin–a2 plasmin inhibitor complex (PIC) 10 mg/L. (2)
Laboratory ﬁndings – at least two of the following ﬁndings: (1)
FDP 80 mg/ml, (2) ﬁbrinogen <100 mg/dl, and (3) increased FDP/
D-dimer ratio (decreased D-dimer/FDP ratio). (3) Reference ﬁndings
– more severe bleeding is likely with the following ﬁndings: (1)
decreased platelet count (<50,000/mL) and (2) decreased a2
plasmin inhibitor activity (<50%) [7]. In the present case, FDP and
ﬁbrinogen were 107.2 mg/ml and 82 mg/dl, respectively. Since
tranexamic acid was effective, the process of ﬁbrinolysis played a
pivotal role in coagulopathy in the present case; however, the
diagnosis regarding ﬁbrinolysis-dominant DIC was incomplete in
the present case. In general, the use of tranexamic acid for anti-
ﬁbrinolytic therapy is not recommended for patients with DIC.
Furthermore, there is the possibility that such therapy could
exacerbate the coagulopathy; therefore, it is necessary to consider
whether the coagulopathy is primarily caused by ﬁbrinolysis-
dominant DIC. To conﬁrm the diagnosis, we should assess the
values of TAT and PIC in the present case.
The mechanism responsible for the association of DIC with
aortic aneurysm is unknown; however, chronic existence of
intraluminal thrombosis might play an important role in the
pathogenesis of DIC via an inﬂammatory process or as a source of
proteinases. Regional intravascular coagulation may occur at the
site of mural thrombosis of aneurysmal aorta. Although it is not‘disseminated,’ it may systemically inﬂuence the coagulation
systems. Recently, Siennicka et al. reported a negative correlation
between tissue plasminogen activator (t-PA) and the thickness of
intraluminal thrombosis of AAA [8]. On the other hand, Aho et al.
reported that there was no relationship between them [9]. Thus,
there is still a controversy between plasma t-PA and the mural
thrombosis of AAA. Pathophysiology of DIC in the aortic aneurysm
is an important subject to be clariﬁed.
Our patient’s aneurysms were gigantic with diameters greater
than 90 mm, and we recognized that she was at an extremely high-
risk of rupture. Surgery or EVAR are safe for treating aged patients
[10,11]. Because of the aging population, the present patient
illustrates the importance of optimizing the treatment of
cardiovascular diseases of the aged.
In summary, we presented a case report of an aged Japanese
woman with AAA associated with DIC, and anti-ﬁbrinolytic
therapy drastically ameliorated her condition. Our experience
illustrates the importance of evaluation of the diameter of an
aneurysm as well as intraluminal thrombosis, which may play an
important role in coagulopathy including DIC. It is necessary to
monitor coagulation and ﬁbrinolysis for the follow-up of patients
with AAA.
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